메뉴 건너뛰기




Volumn 98, Issue 1, 2007, Pages 39-42

Genetic toxicity assessment: Employing the best science for human safety evaluation part IV: A strategy in genotoxicity testing in drug development: Some examples

Author keywords

Drug safety; Genotoxicity battery; Genotoxicity strategy

Indexed keywords

AMES TEST; ARTICLE; CARCINOGENICITY; CHROMOSOME ABERRATION; CYTOTOXICITY; DECISION TREE; DRUG RESEARCH; DRUG SAFETY; GENOTOXICITY; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MICRONUCLEUS TEST; NONHUMAN; RISK ASSESSMENT; TOXICITY TESTING;

EID: 34447551703     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm056     Document Type: Article
Times cited : (18)

References (13)
  • 1
    • 0023010822 scopus 로고
    • Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations
    • Brusick, D. (1986). Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen 8, 879-886.
    • (1986) Environ Mutagen , vol.8 , pp. 879-886
    • Brusick, D.1
  • 2
    • 34447508483 scopus 로고    scopus 로고
    • Food and Drug Administration (FDA) (2006). Food and Drug Administration - U.S. Department of Health and Human Services (2006). Guidance for Industry and Review Staff - Recommended Approaches to Integration of Genetic Toxicology Study Results. Food and Drug Administration. http://www.fda.gov
    • Food and Drug Administration (FDA) (2006). Food and Drug Administration - U.S. Department of Health and Human Services (2006). Guidance for Industry and Review Staff - Recommended Approaches to Integration of Genetic Toxicology Study Results. Food and Drug Administration. http://www.fda.gov
  • 4
    • 0035070535 scopus 로고    scopus 로고
    • Evaluation of the rodent micronucleus assay by a 28-day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)-Mammalian Mutagenicity Study Group (MMS)
    • Hamada, S., Sutou, S., Morita, T., Wakata, A., Anasami, S., Hosoya, S., Ozawa, S., Kondo, K., Nakajima, M., Shimada, et al. (2001). Evaluation of the rodent micronucleus assay by a 28-day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)-Mammalian Mutagenicity Study Group (MMS). Env. Mol. Mutagen 37, 93-110.
    • (2001) Env. Mol. Mutagen , vol.37 , pp. 93-110
    • Hamada, S.1    Sutou, S.2    Morita, T.3    Wakata, A.4    Anasami, S.5    Hosoya, S.6    Ozawa, S.7    Kondo, K.8    Nakajima, M.9    Shimada10
  • 7
    • 33847759457 scopus 로고    scopus 로고
    • International Workshop on Genotoxicity Testing (IWGT) (2007). Reports of the 4th International Workshop on Genotoxicity Testing (IWGT), 9-10 September 2005, San Francisco, CA, USA. In Mutation Research (D. J. Kirkland, M. Hayashi, D. Jacobson-Kram, P. Kasper, J. T. MacGregor, L. Muller, and Y. Uno, Eds.), 627, pp. 1-118. Elsevier. Amsterdam
    • International Workshop on Genotoxicity Testing (IWGT) (2007). Reports of the 4th International Workshop on Genotoxicity Testing (IWGT), 9-10 September 2005, San Francisco, CA, USA. In Mutation Research (D. J. Kirkland, M. Hayashi, D. Jacobson-Kram, P. Kasper, J. T. MacGregor, L. Muller, and Y. Uno, Eds.), Vol. 627, pp. 1-118. Elsevier. Amsterdam
  • 8
    • 0342288641 scopus 로고    scopus 로고
    • Interpretation of the biological relevance of genotoxicity test results: The importance of thresholds
    • Kirkland, D.J., and Mueller, L. (2000). Interpretation of the biological relevance of genotoxicity test results: The importance of thresholds. Mutat. Res. 464, 137-147.
    • (2000) Mutat. Res , vol.464 , pp. 137-147
    • Kirkland, D.J.1    Mueller, L.2
  • 9
    • 21544473568 scopus 로고    scopus 로고
    • Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity
    • Kirkland, D., Aardema, M., Henderson, L., and Mueller, L. (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584, 1-256.
    • (2005) Mutat. Res , vol.584 , pp. 1-256
    • Kirkland, D.1    Aardema, M.2    Henderson, L.3    Mueller, L.4
  • 10
    • 33847325174 scopus 로고    scopus 로고
    • How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-ip animal tests: Report of an ECVAM workshop
    • doi:10.1016/j.mrgentox.2006.11.008
    • Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., et al. (2007). How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-ip animal tests: Report of an ECVAM workshop. Mutat. Res. 628, 31-55. doi:10.1016/j.mrgentox.2006.11.008
    • (2007) Mutat. Res , vol.628 , pp. 31-55
    • Kirkland, D.1    Pfuhler, S.2    Tweats, D.3    Aardema, M.4    Corvi, R.5    Darroudi, F.6    Elhajouji, A.7    Glatt, H.8    Hastwell, P.9    Hayashi, M.10
  • 11
    • 0342316476 scopus 로고    scopus 로고
    • Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: Experience with pharmaceuticals
    • Mueller, L. and Kasper, P. (2000). Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: Experience with pharmaceuticals. Mutat. Res. 464, 19-34.
    • (2000) Mutat. Res , vol.464 , pp. 19-34
    • Mueller, L.1    Kasper, P.2
  • 12
    • 0032764344 scopus 로고    scopus 로고
    • A Micromethod for the in vitro Micronucleus Assay
    • Nesslany, F., and Marzin, D. (1999). A Micromethod for the in vitro Micronucleus Assay. Mutagenesis. 14, 403-410.
    • (1999) Mutagenesis , vol.14 , pp. 403-410
    • Nesslany, F.1    Marzin, D.2
  • 13
    • 0030697498 scopus 로고    scopus 로고
    • The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene
    • Storer, R.D., Kraynak, A.R., McKelvey, T.W., Elia, M.C., Goodrow, T.L., DeLuca, J.G. (1997). The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat. Res. 373, 157-165.
    • (1997) Mutat. Res , vol.373 , pp. 157-165
    • Storer, R.D.1    Kraynak, A.R.2    McKelvey, T.W.3    Elia, M.C.4    Goodrow, T.L.5    DeLuca, J.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.